Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Illner

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|October 1, 1987
Combined kidney/pancreas transplantation--poor long-term outcome of renal graftsG Hillebrand, L A Castro, R Landgraf, et al.
Transplantation Proceedings|October 1, 1990
Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantationH F Welter, W D Illner, S Schleibner, et al.
Diabetologia|August 1, 1991
Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantationR Landgraf, J Nusser, R L Riepl, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Early infiltration of renal allografts with 27E10-positive macrophages and graft outcomeK Burkhard, G O Hofmann, A Bösnecker, et al.
Transplantation Proceedings|August 1, 1992
Kidney transplantation in the cyclosporine era--the Munich experienceH Schneeberger, S Schleibner, W D Illner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1988
First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patientsW Land, G Hillebrand, W D Illner, et al.
Transplantation Proceedings|October 1, 1990
Prevention of acute renal failure after kidney transplantation by treatment with rh-SOD: interim analysis of a double-blind placebo-controlled trialH Schneeberger, S Schleibner, M Schilling, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survivalH Schneeberger, S Aydemir, R Müller, et al.
Transplantation Proceedings|August 1, 1990
Metabolic studies of type I diabetics after successful segmental pancreas and kidney transplantationR Landgraf, J Nusser, M M Landgraf-Leurs, et al.
Transplantation|July 29, 1998
Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipientsB Zanker, H Schneeberger, U Rothenpieler, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|October 1, 1987
Combined kidney/pancreas transplantation--poor long-term outcome of renal graftsG Hillebrand, L A Castro, R Landgraf, et al.
Transplantation Proceedings|October 1, 1990
Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantationH F Welter, W D Illner, S Schleibner, et al.
Diabetologia|August 1, 1991
Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantationR Landgraf, J Nusser, R L Riepl, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Early infiltration of renal allografts with 27E10-positive macrophages and graft outcomeK Burkhard, G O Hofmann, A Bösnecker, et al.
Transplantation Proceedings|August 1, 1992
Kidney transplantation in the cyclosporine era--the Munich experienceH Schneeberger, S Schleibner, W D Illner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 1988
First clinical experience with a new TCR/CD3-monoclonal antibody (BMA 031) in kidney transplant patientsW Land, G Hillebrand, W D Illner, et al.
Transplantation Proceedings|October 1, 1990
Prevention of acute renal failure after kidney transplantation by treatment with rh-SOD: interim analysis of a double-blind placebo-controlled trialH Schneeberger, S Schleibner, M Schilling, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survivalH Schneeberger, S Aydemir, R Müller, et al.
Transplantation Proceedings|August 1, 1990
Metabolic studies of type I diabetics after successful segmental pancreas and kidney transplantationR Landgraf, J Nusser, M M Landgraf-Leurs, et al.
Transplantation|July 29, 1998
Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipientsB Zanker, H Schneeberger, U Rothenpieler, et al.
Pageof 11